Advertisement

Coronaviruses pp 455-463 | Cite as

Genetically-Determined Sensitivity to MHV3 Infections is Expressed in Vitro in Lymphoid Cells and Macrophages

  • J. M. Dupuy
  • L. Lamontagne
Chapter
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 218)

Abstract

Natural resistance of mice to viruses is an excellent model to study genetically-controlled virus-lymphoid cell interactions. Hepatitis virus type 3 (MHV3) infection displays various types of sentivity according to the mouse strains tested: resistance, full susceptibility to acute disease or semisusceptibility which is characterized by the occurrence of persistent viral infection with development of neurological signs. A/J strain mice are resistant to MHV3 infection but immunosuppressive treatments can abrogate the resistance1. Protection of newborn mice against MHV3 infection requires the transfer of several populations originating from adult syngeneic donors: adherent spleen cells, thymocytes and a third population present in the non-adherent spleen cell fraction, in peritoneal exudate and bone marrow cells2.

Keywords

Peritoneal Exudate Peritoneal Exudate Cell Mouse Hepatitis Virus Infectious Viral Particle Persistent Viral Infection 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    J.M. Dupuy, E. Levy-Leblond, and C. Le Prévost, Iramunopathology of mouse hepatitis virus type 3 infection. II. Effect of immuno-suppression in resistant mice, J. Immun., 114: 226 (1975).PubMedGoogle Scholar
  2. 2.
    M. Tardieu, C. Hery, and J.M. Dupuy, Neonatal susceptibility to MHV3 infection in mice. II. Role of natural effector marrow cells in transfer of resistance, J. Immun., 124: 418 (1980).PubMedGoogle Scholar
  3. 3.
    D. Leray, C. Dupuy, and J.M. Dupuy, Immunopathology of mouse hepatitis virus type 3 infection. IV. MHV3-induced immunosuppression, Clin. Immunol. Immunopathol., 23: 1457 (1982).CrossRefGoogle Scholar
  4. 4.
    C. Le Prévost, J.L. Virelizier, and J.M. Dupuy, Immunopathology of mouse hepatitis virus type 3 infection. III. Clinical and virological observation of a persistent viral infection, J. Immunol., 115: 640 (1975).PubMedGoogle Scholar
  5. 5.
    E. Levy-Lebond, D. Oth, and J.M. Dupuy, Genetic study of mouse sensitivity to MHV3 infection: influence of the H-2 complex, J. Immunol., 112: 1359 (1979).Google Scholar
  6. 6.
    H. Arnheiter, T. Baechi, and O. Haller, Adult mouse hepatocytes in primary monolayer culture express genetic resistance to mouse hepatitis virus type 3, J. Immunol., 129: 1275 (1982).PubMedGoogle Scholar
  7. 7.
    L.M. Lamontagne and J.M. Dupuy, Natural resistance of mice to mouse hepatitis virus type 3 infection is expressed in embryonic fibroblast cells, J. Gen. Virol., 65: 1165 (1984).PubMedCrossRefGoogle Scholar
  8. 8.
    J.L. Virelizier and A.C. Allison, Correlation of persistent mouse hepatitis virus (MHV3) infection with its effect on mouse macrophage cultures, Arch. Virol., 50: 279 (1976).PubMedCrossRefGoogle Scholar
  9. 9.
    C. Dupuy, D. Lafforet-Cresteil, and J,M. Dupuy, Genetic study of MHV3 infection in mice: in vitro replication of virus in macrophages, in: “Genetic control of natural resistance to infection and malignancy”, E. Skamene, P.A.L. Kongshavn and M. Landry, eds, Academic Press, New York (1980).Google Scholar
  10. 10.
    M.R. MacNaughton and S. Patterson, Mouse hepatitis virus strain 3 infection of C57, A/Sn and A/J strain mice and their macrophages, Arch. Virol., 66: 71 (1980).PubMedCrossRefGoogle Scholar
  11. 11.
    J.M. Dupuy and D. Rodrigue, Heterogeneity in evolutive patterns of inbred mice infected with a cloned substrain of mouse hepatitis virus type 3, Intervirology, 16: 114 (1981).PubMedCrossRefGoogle Scholar
  12. 12.
    A.S. Huang and D. Baltimore, Defective viral particles and viral disease processes, Nature Lond., 226: 325 (1970).PubMedCrossRefGoogle Scholar
  13. 13.
    M.J. Sekellick and P.I. Marcus, Persistent infection. II. Interferon-inducing temperature-sensitive mutants as mediators of cell sparing: possible role in persistent infection by vesicular stomatitis virus, Virology, 95: 36 (1979).PubMedCrossRefGoogle Scholar
  14. 14.
    H. Dahl and M. Degré, A microassay for mouse and human Interferon, Acta. Pathol., Microbiol. Scand. Sect. B, 80: 863 (1972).Google Scholar
  15. 15.
    L.M. Lamontagne and J.M. Dupuy, Persistent infection with mouse hepatitis virus type 3 in mouse lymphoid cell lines, Infect. & Immun., 44: 716 (1984).Google Scholar
  16. 16.
    W. Weiser and F.B. Bang, Macrophages genetically resistant to mouse hepatitis virus converted in vitro in susceptible macrophages, J. Exp. Med., 143: 690 (1976).PubMedCrossRefGoogle Scholar
  17. 17.
    S.A. Stohlman, J.G. Woodward, and J.A. Frelinger, Macrophage antiviral activity: extrinsic versus intrinsic activity, Infect. & Immunol. 36: 672 (1982).Google Scholar
  18. 18.
    M. Piazza, G. Pane, and F. De Ritis, The fate of MHV3 after intra-veinous injection into susceptible mice, Arch. Ges. Virusforsch., 22: 472 (1967).PubMedCrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1987

Authors and Affiliations

  • J. M. Dupuy
    • 1
  • L. Lamontagne
    • 1
  1. 1.Immunology Research Center, Institut Armand-Frappier, and Dépt Sciences BiologiquesUniversité du Québec à MontréalMontréalCanada

Personalised recommendations